FDA halts Avandia trial enrollment
The U.S. Food and Drug Administration (FDA) notified GlaxoSmithKline that the post-marketing trial of Avandia (rosiglitazone) is on “partial clinical hold,” meaning no new…
Technology
Patient handling: Fact vs. Fiction
Although the hazards of manual patient lifting and transferring are well known, misinformation persists.
Issues up close
ANA’s “Bringing Immunity to Every Community” campaign aims to boost RNs’ knowledge of immunization, encourage them to get vaccinated, and position them as leading…
Whooping cough makes an unwanted comeback
Have you ever heard a child with pertussis (whooping cough)? Chances are, thanks to decades of pertussis vaccines, you haven’t. Watch a video of…
Technology: The great enabler
Where would you be without a “smart” phone to manage your life? We’ve adapted to noxious ring tones; how have we adapted to technology…
FDA approves new drug for osteoporosis
On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who are at…
Digital dashboards and staffing
Many healthcare organizations use digital “dashboards” to provide employees with real-time data collected from various sources, helping to guide decisions and improve the quality…
How inflammatory markers refine CV risk status
Cardiovascular disease (CVD) originates from atherosclerosis, a disease in which low-density lipoprotein (LDL) particles build up in the arterial wall.
Genetic/Genomic Competency Center
The Genetic/Genomic Competency Center (G2C2, http://www.g-2-c-2.org/) is a new free online resource created to help educators teach the next generation of nurses and physician…
FDA clears STERIS system
On April 5, the U.S. Food and Drug Administration cleared the STERIS System 1E Liquid Chemical Sterilant Processing System. The device is used to…
FDA approves new device for asthma
On April 27, the U.S. Food and Drug Administration approved the first medical device that uses radiofrequency energy to treat severe and persistent asthma…
New online resource: Genetic/Genomic Competency Center
The Genetic/Genomic Competency Center (G2C2, http://www.g-2-c-2.org/) is a new free online resource created to help educators teach the next generation of nurses and physician…
FDA halts Avandia trial enrollment
The U.S. Food and Drug Administration (FDA) notified GlaxoSmithKline that the post-marketing trial of Avandia (rosiglitazone) is on “partial clinical hold,” meaning…
Patient handling: Fact vs. Fiction
Although the hazards of manual patient lifting and transferring are well known, misinformation persists.
Issues up close
ANA’s “Bringing Immunity to Every Community” campaign aims to boost RNs’ knowledge of immunization, encourage them to get vaccinated, and position them…
Whooping cough makes an unwanted comeback
Have you ever heard a child with pertussis (whooping cough)? Chances are, thanks to decades of pertussis vaccines, you haven’t. Watch a…
Technology: The great enabler
Where would you be without a “smart” phone to manage your life? We’ve adapted to noxious ring tones; how have we adapted…
FDA approves new drug for osteoporosis
On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who…
Digital dashboards and staffing
Many healthcare organizations use digital “dashboards” to provide employees with real-time data collected from various sources, helping to guide decisions and improve…
How inflammatory markers refine CV risk status
Cardiovascular disease (CVD) originates from atherosclerosis, a disease in which low-density lipoprotein (LDL) particles build up in the arterial wall.
Genetic/Genomic Competency Center
The Genetic/Genomic Competency Center (G2C2, http://www.g-2-c-2.org/) is a new free online resource created to help educators teach the next generation of nurses…
FDA clears STERIS system
On April 5, the U.S. Food and Drug Administration cleared the STERIS System 1E Liquid Chemical Sterilant Processing System. The device is…
FDA approves new device for asthma
On April 27, the U.S. Food and Drug Administration approved the first medical device that uses radiofrequency energy to treat severe and…
New online resource: Genetic/Genomic Competency Center
The Genetic/Genomic Competency Center (G2C2, http://www.g-2-c-2.org/) is a new free online resource created to help educators teach the next generation of nurses…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.